Biotechnology Market Research Reports & Industry Analysis

Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.

Biotech Market Research to Fuel Business Growth

Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:

  • Current market performance, industry outlooks, and industry lifecycles
  • Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
  • Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
  • Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies

Stay Ahead with our Biotechnology Industry Analysis

The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.

...Show More ...Show Less


Biotechnology Industry Research & Market Reports

  • Personalized Nutrition

    ... CAGR of 13.5% over the analysis period 2024-2030. Active Measurement, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$27.5 Billion by the end of the analysis ... Read More

  • Plant Genomics

    ... CAGR of 8.0% over the analysis period 2024-2030. Molecular Engineering, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.5 Billion by the end of the analysis ... Read More

  • Portable Gas Chromatographs

    ... at a CAGR of 6.1% over the analysis period 2024-2030. Portable Gas Chromatograph Systems, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More

  • Process Spectroscopy

    ... CAGR of 6.6% over the analysis period 2024-2030. Process Spectroscopy Hardware, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$26.2 Billion by the end of the ... Read More

  • Real-time PCR (qPCR) and Digital PCR (dPCR)

    ... expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR ... Read More

  • Scaffold Technology

    ... CAGR of 7.0% over the analysis period 2024-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More

  • Short-Read Sequencing

    ... CAGR of 10.0% over the analysis period 2024-2030. Next-Generation Sequencing Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$25.0 Billion by the end of the ... Read More

  • Tissue Engineering

    ... CAGR of 12.5% over the analysis period 2024-2030. Orthopedics, Musculoskeletal & Spine Application, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by the end ... Read More

  • Tissue Engineered Skin Substitutes

    ... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Biological Skin Substitutes, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.9 Billion by ... Read More

  • Plant Cell Culture Equipment

    ... 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$784.8 Million by the end ... Read More

  • Predictive Genetic Testing and Consumer Genomics

    ... reach US$20.7 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Predictive Testing, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach ... Read More

  • Orthopedic Bone Cement

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$944.8 Million by the ... Read More

  • Bovine Serum Albumin

    ... at a CAGR of 3.9% over the analysis period 2024-2030. Dry Form, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$254.3 Million by the end of ... Read More

  • Chromatography Instruments

    ... CAGR of 4.9% over the analysis period 2024-2030. Liquid Chromatography Systems, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.6 Billion by the end of the ... Read More

  • CRISPR Technology

    ... CAGR of 20.9% over the analysis period 2024-2030. CRISPR Products, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$6.1 Billion by the end of the analysis ... Read More

  • FISH Probe

    ... CAGR of 5.9% over the analysis period 2024-2030. Q-FISH Technology, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$638.3 Million by the end of the analysis ... Read More

  • Food Enzymes

    ... CAGR of 6.1% over the analysis period 2024-2030. Microorganisms Source Enzymes, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.6 Billion by the end of the ... Read More

  • Fruit and Vegetable Processing Enzymes

    ... Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$24.6 Billion by ... Read More

  • Genomics in Cancer Care

    ... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Genomics Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the ... Read More

  • Glucose Biosensors

    ... CAGR of 2.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More

  • Immunomodulators

    ... 5.7% over the analysis period 2024-2030. Immunosuppressants, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$209.8 Million by the end of the analysis period. Growth in ... Read More

  • Immunoprecipitation

    ... 5.8% over the analysis period 2024-2030. Immunoprecipitation Reagents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$457.9 Million by the end of the analysis period. Growth ... Read More

  • In Vivo Contract Research Organization (CRO)

    ... reach US$8.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and ... Read More

  • Mammalian Polyclonal IgG Antibody

    ... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Metabolic Markers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$532.1 Million by the ... Read More

  • Metagenomic Sequencing

    ... CAGR of 17.6% over the analysis period 2024-2030. Metagenomic Sequencing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.4% CAGR and reach US$4.3 Billion by the end ... Read More

Cookie Settings